programme
08.45 Registration
Opening Session
09.00 3rd Edition Students of BiotechHealth
Morning Session
09.15 Using organoids to model patient response
René Overmeer
Foundation Hubrecht Organoid Technology, Utrecht, The Netherlands
10.00 Targeting unmet medical needs in oncology with nanomedicine-based strategies
João Nuno Moreira
Center for Neuroscience and Cell Biology, Coimbra, Portugal
10.45 Coffee Break
11.45 Next generation immunotherapies for colorectal cancer
Noel de Miranda
Leiden University Medical Center, Leiden, The Netherlands
11.50 Multiplexing in intact tissue section. Unlocking the secrets surrounding Immune cells
Bjoern Wendik
PerkinElmer, Freiburg, Germany
12.30 Lunch
Afternoon Session
14.00 Genetic factors underlying cardiovascular diseases: how to prevent the damage?
Susana Santos
HeartGenetics, Lisbon, Portugal
14.45 Imaging biomarkers and radiomics: techniques and clinical applications with a focus on
cancer
Nikolaos Papanikolaou
Champalimaud Foundation, Lisbon, Portugal
15.30 Coffee Break
15.50 More data ≠ better data: real world evidence and the power of structured clinical data in
oncology
Miguel Borges
OncoStats, Braga, Portugal
Closing Session
16.40 Porto d’Honra and i3S Choir
IV BiotechHealth Annual Symposium
Sp tting the
differences:
Biotechnology driving precision medicine
4 July 2017 | i3S | Porto
WELCOME
Welcome to the IV BiotechHealth Annual Symposium.
With the aim of providing the right drug, for the right patient, at the right time, precision medicine allows the tailoring of clinical decisions towards individual patients through their stratification into well-defined subpopulations, based on their genetic, cellular and molecular profiles.
Placed at the interface of basic research and clinical implementation, biotechnology has been a crucial source of cutting-edge tools and platforms responsible for overcoming technical challenges and driving precision medicine to a closer reality. Indeed, biotechnology has played a central role in pushing precision medicine forward, namely through the acquisition and integration of massive amounts of clinical data brought to us by novel OMIC approaches and the development of sophisticated in vitro, ex vivo and in vivo models of human pathologies of increasing complexity and heterogeneity.
We hope that talks from renowned national and international speakers, addressing different approaches to the emerging concept of precision medicine, will stimulate rewarding discussions and help both the academic and scientific community to understand which steps still need to be taken in order to bring precision medicine closer to patients.
SPEAKERS
René Overmeer
HUB
João Nuno Moreira
CNC
Noel de Miranda
LUMC
Bjoern Wendik
PerkinElmer
Susana Santos
HeartGenetics
Nikolaos Papanikolaou
Champalimaud Foundation
Miguel Borges
OncoStats
Location & venue
The meeting will be held at i3S – Instituto de Investigação e Inovação em Saúde, University of Porto.
Rua Alfredo Allen, 208; 4200-135 Porto, Portugal. (How to get to i3S)
Site: http://www.i3s.up.pt/
E-mail: info@i3s.up.pt
Tel: +351 220 408 800
GPS coordinates: 41º 10’ 30.008’’ N, 8º 36’ 12.488’’ W.
BiotechHealth
BiotechHealth is an international PhD programme of the University of Porto. With an innovative multidisciplinary nature, it strives for excellence in doctoral training in the fields of cellular and molecular biotechnology applied to health sciences. BiotechHealth’s main goal is to translate research into clinical and industrial applications.
Porto: European Best Destination 2017
City of history, architecture, culture, gastronomy, trade, and sea, Porto was elected, for the third time, as Best European Destination 2017. According to worldwide travellers “you will find it hard to leave”.